|
The
Foundry®
Investors
The
Foundry is funded by Split Rock
Partners and Morgenthaler
Ventures. One important reason why The Foundry is such a valuable
partner is its strong financial backing and close relationships
with experienced entrepreneurs and investors in the medical device
community. As such, The Foundry has helped raise over $200 million
for our portfolio
companies in various stages of financings
from such notable venture capital firms as:
ABS
Ventures
Advanced Technology Ventures
Bluebird Development, LLC
Cutlass Capital
Delphi Ventures
Frazier Healthcare Ventures
H & Q Capital Management
Latterell Venture Partners
Morgan
Stanley
Morgenthaler
New Enterprise Associates
New Venture Partners
Neuroventures
OrbiMed Advisors
Oxford Bioscience Partners
Proquest
Schroder Ventures Life Sciences
Split Rock Partners, co-manager of St. Paul Venture Capital
Three Arch Partners
Venrock Associates
|